BIOMAT Database Logo BIOMAT Database Logo

Efficacy of polymyxin B hemoperfusion in and beyond septic shock: is an "endotoxin severity score" needed? 2018

Patrick M Honore, and David De Bels, and Thierry Preseau, and Sebastien Redant, and Herbert D Spapen
ICU Department, Centre Hospitalier Universitaire Brugmann, Place Van Gehuchtenplein 4, 1020, Brussels, Belgium. Patrick.Honore@CHU-Brugmann.be.

UI MeSH Term Description Entries
D011112 Polymyxin B A mixture of polymyxins B1 and B2, obtained from BACILLUS POLYMYXA strains. They are basic polypeptides of about eight amino acids and have cationic detergent action on cell membranes. Polymyxin B is used for treatment of infections with gram-negative bacteria, but may be neurotoxic and nephrotoxic. Aerosporin,Polymyxin B Sulfate
D004731 Endotoxins Toxins closely associated with the living cytoplasm or cell wall of certain microorganisms, which do not readily diffuse into the culture medium, but are released upon lysis of the cells. Endotoxin
D006464 Hemoperfusion Removal of toxins or metabolites from the circulation by the passing of blood, within a suitable extracorporeal circuit, over semipermeable microcapsules containing adsorbents (e.g., activated charcoal) or enzymes, other enzyme preparations (e.g., gel-entrapped microsomes, membrane-free enzymes bound to artificial carriers), or other adsorbents (e.g., various resins, albumin-conjugated agarose). Hemosorption,Hemoperfusions,Hemosorptions
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D012772 Shock, Septic Sepsis associated with HYPOTENSION or hypoperfusion despite adequate fluid resuscitation. Perfusion abnormalities may include but are not limited to LACTIC ACIDOSIS; OLIGURIA; or acute alteration in mental status. Endotoxin Shock,Septic Shock,Shock, Endotoxic,Shock, Toxic,Toxic Shock,Toxic Shock Syndrome,Endotoxin Shocks,Shock Syndrome, Toxic,Shock, Endotoxin,Shocks, Endotoxin,Toxic Shock Syndromes
D015331 Cohort Studies Studies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesized to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics. Birth Cohort Studies,Birth Cohort Study,Closed Cohort Studies,Cohort Analysis,Concurrent Studies,Historical Cohort Studies,Incidence Studies,Analysis, Cohort,Cohort Studies, Closed,Cohort Studies, Historical,Studies, Closed Cohort,Studies, Concurrent,Studies, Historical Cohort,Analyses, Cohort,Closed Cohort Study,Cohort Analyses,Cohort Studies, Birth,Cohort Study,Cohort Study, Birth,Cohort Study, Closed,Cohort Study, Historical,Concurrent Study,Historical Cohort Study,Incidence Study,Studies, Birth Cohort,Studies, Cohort,Studies, Incidence,Study, Birth Cohort,Study, Closed Cohort,Study, Cohort,Study, Concurrent,Study, Historical Cohort,Study, Incidence

Related Publications

Patrick M Honore, and David De Bels, and Thierry Preseau, and Sebastien Redant, and Herbert D Spapen
Efficacy of polymyxin B-immobilized fiber column direct hemoperfusion for non-endotoxin-associated severe septic shock.
December 2016, Pediatrics international : official journal of the Japan Pediatric Society,
Patrick M Honore, and David De Bels, and Thierry Preseau, and Sebastien Redant, and Herbert D Spapen
Polymyxin B hemoperfusion and mortality in abdominal septic shock.
November 2009, JAMA,
Patrick M Honore, and David De Bels, and Thierry Preseau, and Sebastien Redant, and Herbert D Spapen
Polymyxin B hemoperfusion and mortality in abdominal septic shock.
November 2009, JAMA,
Patrick M Honore, and David De Bels, and Thierry Preseau, and Sebastien Redant, and Herbert D Spapen
Polymyxin B hemoperfusion and mortality in abdominal septic shock.
November 2009, JAMA,
Patrick M Honore, and David De Bels, and Thierry Preseau, and Sebastien Redant, and Herbert D Spapen
Is postoperative polymyxin B hemoperfusion for abdominal septic shock really ineffective?
August 2014, Critical care medicine,
Patrick M Honore, and David De Bels, and Thierry Preseau, and Sebastien Redant, and Herbert D Spapen
Is postoperative polymyxin B hemoperfusion for abdominal septic shock really ineffective?
August 2014, Critical care medicine,
Patrick M Honore, and David De Bels, and Thierry Preseau, and Sebastien Redant, and Herbert D Spapen
Preliminary results of polymyxin B hemoperfusion in abdominal septic shock.
November 2017, Revista espanola de anestesiologia y reanimacion,
Patrick M Honore, and David De Bels, and Thierry Preseau, and Sebastien Redant, and Herbert D Spapen
Polymyxin B hemoperfusion in septic shock: nothing overmuch (Meden Agan)!
September 2017, Journal of thoracic disease,
Patrick M Honore, and David De Bels, and Thierry Preseau, and Sebastien Redant, and Herbert D Spapen
Polymyxin B-immobilized fiber column hemoperfusion therapy for septic shock.
October 2011, Shock (Augusta, Ga.),
Patrick M Honore, and David De Bels, and Thierry Preseau, and Sebastien Redant, and Herbert D Spapen
Polymyxin B-immobilized fiber column hemoperfusion therapy for septic shock.
September 2013, Shock (Augusta, Ga.),
Copied contents to your clipboard!